References
Rosenberg, J. H., Werner, J. H., Moulton, M. J., & Agrawal, D. K. (2018). Current modalities and mechanisms underlying cardioprotection by ischemic conditioning. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-018-9813-1.
Dominguez-Rodriguez, A., Abreu-Gonzalez, P., & Reiter, R. J. (2017). Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge? Heart, 103(9), 647–648. https://doi.org/10.1136/heartjnl-2016-310689.
Zhou, H., Ma, Q., Zhu, P., Ren, J., Reiter, R. J., & Chen, Y. (2018). Protective role of melatonin in cardiac ischemia-reperfusion injury: from pathogenesis to targeted therapy. Journal of Pineal Research, 64(3). https://doi.org/10.1111/jpi.12471.
Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J. M., et al. (2017). Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial. Journal of Pineal Research, 62(1). https://doi.org/10.1111/jpi.12374.
Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J. M., et al. (2017). Usefulness of early treatment with melatonin to reduce infarct size in patients with ST-segment elevation myocardial infarction receiving percutaneous coronary intervention (from the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial). The American Journal of Cardiology, 120(4), 522–526. https://doi.org/10.1016/j.amjcard.2017.05.018.
Acknowledgements
The authors thank Ines Abreu-Afonso for her linguistic revision of this manuscript.
Funding
This research was funded by the Institute Carlos III (ISCIII) (PI15/01260), General Branch Evaluation and Research Promotion, State Plan of Scientific and Technical Research and Innovation 2013–2016, and European Regional Development Fund Health–FEDER.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
A.D-R and P.A-G have a patent to the use of melatonin in ST-elevation myocardial infarction (P201400743). The other author reports no conflict of interest.
Ethical Approval
This article does not contain any studies with humans neither with animals.
Additional information
Associate Editor Junjie Xiao oversaw the review of this article
Rights and permissions
About this article
Cite this article
Dominguez-Rodriguez, A., Baez-Ferrer, N. & Abreu-Gonzalez, P. Melatonin and ST Segment Elevation Acute Myocardial Infarction—the “Forgotten Cardioprotective Therapy” Strikes Again. J. of Cardiovasc. Trans. Res. 11, 308–309 (2018). https://doi.org/10.1007/s12265-018-9815-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-018-9815-z